101 related articles for article (PubMed ID: 16509964)
1. The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations.
Rudkin TM; Hamel N; Galvez M; Hogervorst F; Gille JJ; Møller P; Apold J; Foulkes WD
BMC Med Genet; 2006 Mar; 7():15. PubMed ID: 16509964
[TBL] [Abstract][Full Text] [Related]
2. Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.
Oros KK; Leblanc G; Arcand SL; Shen Z; Perret C; Mes-Masson AM; Foulkes WD; Ghadirian P; Provencher D; Tonin PN
BMC Med Genet; 2006 Mar; 7():23. PubMed ID: 16539696
[TBL] [Abstract][Full Text] [Related]
3. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
4. Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population.
Pertesi M; Konstantopoulou I; Yannoukakos D
Clin Genet; 2011 Oct; 80(4):375-82. PubMed ID: 20840220
[TBL] [Abstract][Full Text] [Related]
5. Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
Russo A; Calò V; Bruno L; Schirò V; Agnese V; Cascio S; Foddai E; Fanale D; Rizzo S; Di Gaudio F; Gulotta E; Surmacz E; Di Fede G; Bazan V
Breast Cancer Res Treat; 2009 Jan; 113(1):67-70. PubMed ID: 18228134
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
[TBL] [Abstract][Full Text] [Related]
7. Genetic epidemiology of BRCA1 mutations in Norway.
Møller P; Heimdal K; Apold J; Fredriksen A; Borg A; Hovig E; Hagen A; Hagen B; Pedersen JC; Maehle L; ;
Eur J Cancer; 2001 Dec; 37(18):2428-34. PubMed ID: 11720839
[TBL] [Abstract][Full Text] [Related]
8. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
[TBL] [Abstract][Full Text] [Related]
9. Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore.
Lee AS; Ho GH; Oh PC; Balram C; Ooi LL; Lim DT; Wong CY; Hong GS
Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872263
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.
Infante M; Durán M; Acedo A; Pérez-Cabornero L; Sanz DJ; García-González M; Beristain E; Esteban-Cardeñosa E; de la Hoya M; Teulé A; Vega A; Tejada MI; Lastra E; Miner C; Velasco EA
Clin Genet; 2010 Jan; 77(1):60-9. PubMed ID: 19912264
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.
Baudi F; Quaresima B; Grandinetti C; Cuda G; Faniello C; Tassone P; Barbieri V; Bisegna R; Ricevuto E; Conforti S; Viel A; Marchetti P; Ficorella C; Radice P; Costanzo F; Venuta S
Hum Mutat; 2001 Aug; 18(2):163-4. PubMed ID: 11462242
[TBL] [Abstract][Full Text] [Related]
12. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
[TBL] [Abstract][Full Text] [Related]
13. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
Simard J; Tonin P; Durocher F; Morgan K; Rommens J; Gingras S; Samson C; Leblanc JF; Bélanger C; Dion F
Nat Genet; 1994 Dec; 8(4):392-8. PubMed ID: 7894492
[TBL] [Abstract][Full Text] [Related]
14. Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy.
Papi L; Putignano AL; Congregati C; Zanna I; Sera F; Morrone D; Falchetti M; Turco MR; Ottini L; Palli D; Genuardi M
Breast Cancer Res Treat; 2009 Oct; 117(3):497-504. PubMed ID: 18821011
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
16. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
17. Chasing the origin of 23 recurrent BRCA1 mutations in Pakistani breast and ovarian cancer patients.
Rashid MU; Muhammad N; Naeemi H; Shehzad U; Hamann U
Int J Cancer; 2022 Aug; 151(3):402-411. PubMed ID: 35377489
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
Caligo MA; Ghimenti C; Cipollini G; Ricci S; Brunetti I; Marchetti V; Olsen R; Neuhausen S; Shattuck-Eidens D; Conte PF; Skolnick MH; Bevilacqua G
Oncogene; 1996 Oct; 13(7):1483-8. PubMed ID: 8875986
[TBL] [Abstract][Full Text] [Related]
19. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
[TBL] [Abstract][Full Text] [Related]
20. The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.
Bergman A; Einbeigi Z; Olofsson U; Taib Z; Wallgren A; Karlsson P; Wahlström J; Martinsson T; Nordling M
Eur J Hum Genet; 2001 Oct; 9(10):787-93. PubMed ID: 11781691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
